Danielle Bocchino

Danielle Bocchino Email and Phone Number

Pharma and Biotech Program and Portfolio Leader @ Regeneron
Danielle Bocchino's Location
New York City Metropolitan Area, United States, United States
Danielle Bocchino's Contact Details
About Danielle Bocchino

I am a project, portfolio, and partnership leader with 20+ years of experience in the pharmaceutical and biotech industries. I am passionate about bringing novel therapies to patients. A collaborative and direct leader, I have a demonstrated ability to partner with executive leadership to drive strategic direction. I’m also adept at bringing cross-functional teams together and establishing goals and direction. I have successfully managed projects in all phases of development, including submissions of initial worldwide marketing applications, and across multiple therapeutic areas. Additionally, I can step in and lead various functional areas and efforts, including regulatory strategy development and submissions, clinical operations, pharmacovigilance planning, and partnership/investor due diligence. Specialties: project management, early phase development, late phase development, global development, biomarkers, collaborations with external partners, regulatory, neuroscience, infectious diseases, diabetes, urology, rare/orphan diseases, due diligence, out-licensing, mentoring

Danielle Bocchino's Current Company Details
Regeneron

Regeneron

View
Pharma and Biotech Program and Portfolio Leader
Danielle Bocchino Work Experience Details
  • Regeneron
    Senior Director, Development Program Management -Hematology Lead
    Regeneron Jan 2021 - Present
    Tarrytown, New York, Us
    I lead the Hematology Development Program Management Team (DPM), a team of people managers and individual contributors. I have oversight of our hematology portfolio—heme-onc and classical heme early and late phase development programs. This entails 1) ensuring we are providing best-in-class program management support to all hematology development programs 2) providing accurate planning for and status communications of the portfolio, and 3) partnering with the Hematology Therapeutic Head to drive the portfolio forward.
  • Abide Therapeutics
    Executive Director
    Abide Therapeutics Jan 2018 - Jun 2019
    At Abide, a clinical-stage biotech focused on neurological disease, I served as Project Leader, Project Manager, and Regulatory Head for our early phase development programs. I was a key contributor in establishing strategic direction at the program, partnering, and corporate levels. I drove the development of clinical asset plans and then operationalized them, helping to advance our lead program into Phase II trials. In addition, I built compliance infrastructure and project management capabilities, coordinated partnership/investor due diligence, and led talent recruitment and team building.In 2019, Abide was acquired by Lundbeck.
  • Abide Therapeutics
    Senior Director
    Abide Therapeutics Jan 2016 - Dec 2017
    Project Leader and Project Manager for portfolio of early-phase neuroscience development programs. Acting Head of Regulatory Affairs.
  • Merck
    Director, Global Project And Alliance Management
    Merck Jan 2015 - Jan 2016
    In this role, I served as project manager on the BACE program, a high priority, $500M+, global Phase III Program in Alzheimers disease. My responsibilities included driving the development of global project plans in collaboration with cross-functional, cross-divisional, and cross-company teams. I managed teams of 20+ members. Additionally, I collaborated with Business Development and R&D teams on multiple out-licensing projects and developed best practices for transfer of assets to external corporate partners. I also mentored and coached junior project management staff.
  • Merck
    Associate Director, Global Project Management
    Merck Aug 2012 - Dec 2015
    In this role, I was the project manager on large, complex, $500M+, global late development programs in diabetes (partnered with Pfizer and now approved and marketed as STEGLATRO/SEGLUROMET/STEGLUJAN), Alzheimer's disease, and urology (out-licensed; approved and marketed as GEMTESA). I also headed change management of and provided subject matter expert input into enterprise-wide project cost capabilities, which enabled more rapid and informed program investment decisions.
  • Merck
    Project Manager, Global Project Management
    Merck May 2010 - Jul 2012
    Lead project manager on a high priority, late phase program in the Respiratory and Immunology R&D Franchise as well as a life-cycle management program in osteoporosis. Managed Respiratory and Immunology R&D Franchise biomarker portfolio.
  • Merck
    Franchise Manager, Franchise And Portfolio Integration
    Merck Aug 2009 - May 2010
    Franchise Manager for Diabetes and Obesity R&D Franchise. Prepared operational reviews on pipeline performance, analyzed pipeline attrition, monitored cycle time variances, resources spent, five year portfolio projections, and identified key program issues.
  • Merck
    Biomarker/Platform Portfolio Manager, Franchise And Portfolio Integration
    Merck Sep 2007 - Aug 2009
    Biomarker Manager for Neuroscience and Oncology R&D Franchises. Facilitated development of biomarker objectives in alignment with Franchise strategies and resource constraints. Monitored progress of biomarker portfolio and prepared status reports for senior leadership. Project Manager on large, priority biomarker projects conducted in collaboration with academic research institutes. Managed MRL biomarker governance committee.
  • Merck
    Associate Project Manager, Mrl Project Management
    Merck Jan 2005 - Aug 2007
    Project Manager for ISENTRESS. Ensured key program milestones were met or exceeded to support late phase development and submission of initial WMA filing. Project Manager for early phase HIV and HCV programs.
  • Bristol-Myers Squibb
    Research Scientist
    Bristol-Myers Squibb 2000 - 2004
    Lawrence Township, Nj, Us
    Medicinal and process chemist responsible for synthesizing compounds for the treatment of CNS disorders.

Danielle Bocchino Skills

Drug Development Pharmaceutical Industry Cross Functional Team Leadership Project Management Oncology R&d Neuroscience Regulatory Submissions Infectious Diseases Project Portfolio Management Leadership Organic Chemistry Biomarkers Biopharmaceuticals Management Drug Develop Pharmaceutics Diabetes Clinical Development Clinical Trials Biotechnology

Danielle Bocchino Education Details

  • Yale University
    Yale University
    Chemistry
  • University Of Pennsylvania
    University Of Pennsylvania
    Chemistry

Frequently Asked Questions about Danielle Bocchino

What company does Danielle Bocchino work for?

Danielle Bocchino works for Regeneron

What is Danielle Bocchino's role at the current company?

Danielle Bocchino's current role is Pharma and Biotech Program and Portfolio Leader.

What is Danielle Bocchino's email address?

Danielle Bocchino's email address is da****@****etx.com

What schools did Danielle Bocchino attend?

Danielle Bocchino attended Yale University, University Of Pennsylvania.

What are some of Danielle Bocchino's interests?

Danielle Bocchino has interest in Fitness And Wellness.

What skills is Danielle Bocchino known for?

Danielle Bocchino has skills like Drug Development, Pharmaceutical Industry, Cross Functional Team Leadership, Project Management, Oncology, R&d, Neuroscience, Regulatory Submissions, Infectious Diseases, Project Portfolio Management, Leadership, Organic Chemistry.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.